Echinocandins in antifungal pharmacotherapy

Patil, Akash, Majumdar, Soumyajit·2017·Journal of Pharmacy and Pharmacology

Cites (231)

Items 201–231 of 231

  1. Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry
    Gerlinde Egerer, Dietmar Arno Reichert, Mathias Wilhelm Pletz, Peter Kaskel, Karl J. Krobot, Johan A. Maertens · 2012 · European journal of medical research
  2. Efficacy of Caspofungin against Aspergillus terreus
    Francesco Barchiesi, Elisabetta Spreghini, Alfredo Santinelli et al. · 2005 · Antimicrobial Agents and Chemotherapy
  3. Dose escalation studies with caspofungin against Candida glabrata
    Marianna Domán, Renátó Kovács, David S. Perlin, Gábor Kardos, Rudolf Gesztelyi, Béla Juhász, Aliz Bozó, László Majoros · 2015 · Journal of Medical Microbiology
  4. Anidulafungin: a novel echinocandin
    José A Vazquez · 2006 · Therapy
  5. The Postantifungal and Paradoxical Effects of Echinocandins Against Candida spp.
    Brad Moriyama, Stacey A. Henning, Scott R Penzak, Thomas J. Walsh · 2012 · Future Microbiology
  6. Anidulafungin: an evidence-based review of its use in invasive fungal infections.
    Susan L. Davis, José A. Vázquez · 2008 · PubMed Central
  7. Monoclonal antibodies against microorganisms
    Richard Alan Polin · 1984 · European Journal of Clinical Microbiology & Infectious Diseases
  8. Topical Delivery of Lipid Based Amphotericin B Gel in the Treatment of Fungal Infection: A Clinical Efficacy, Safety and Tolerability Study in Patients
    Saifuddin Sheikh Ateeq Ahmad · 2014 · Journal of Clinical & Experimental Dermatology Research
  9. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
    M B Agarwal, SanjayK Rathi, N Ratho, R Subramanian · 2006 · PubMed
  10. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B
    F. Meunler, Christine Lambert, Philippe van der Auwera · 1989 · Journal of Antimicrobial Chemotherapy
  11. Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae
    Πέτρος Ιωάννου, Angeliki M. Andrianaki, Tonia Akoumianaki, Irene Kyrmizi, Nathaniel D. Albert, David S. Perlin, George Samonis, Dimitrios P. Kontoyiannis, Georgios Chamilos · 2015 · Antimicrobial Agents and Chemotherapy
  12. Anidulafungin: an evidence-based review of its use in invasive fungal infections
    José Vazquez · 2007 · Core evidence
  13. Synergistic antifungal activity of KB425796-C in combination with micafungin against Aspergillus fumigatus and its efficacy in murine infection models
    Hirohito Kai, Midori YAMASHITA, Ikuko Nakamura, Koji Yoshikawa, Kumiko Nitta, Masato Watanabe, Noriaki Inamura, Akihiko Fujie · 2013 · The Journal of Antibiotics
  14. Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo
    Enrique Calvo, Francisco Javier Pastor, Emilio Mayayo · 2011 · International Journal of Antimicrobial Agents
  15. Actividad antifúngica in vitro de la anidulafungina
    Guillermo Quindós, Elena Eraso · 2008 · Revista Iberoamericana de Micología
  16. Cost-effectiveness of caspofungin versus liposomal amphotericin B in the treatment of systemic fungal infections: a systematic review of economic analyses
    Sóstenes Mistro, Lorena Rosa, Bárbara Gomes, Lígia Amanda Ventura de Oliveira Miranda, Roberto José da Silva Badaró · 2016 · Expert Review of Pharmacoeconomics & Outcomes Research
  17. Broth Microdilution and Time–Kill Testing of Caspofungin, Voriconazole, Amphotericin B and their Combinations Against Clinical Isolates of Candida krusei
    Yasemin Öz, İlknur Dağ, Nuri̇ Kiraz · 2011 · Mycopathologia
  18. Breakthrough Fungemia Due toCandida glabrataDuring Posaconazole Prophylaxis in Hematology Patients Treated with Anidulafungin - Report of 5 Cases
    Vladimir Krcmery, Andrea Demitrovicova, Peter Kisac · 2011 · Journal of Chemotherapy
  19. Anidulafungin compared with fluconazole therapy in critically ill patients
    Daniel H. Kett, AF Shorr, AC Reboli, AC Reisman, Pinaki Biswas, Haran T. Schlamm · 2010 · Critical Care
  20. Clinical efficacy of caspofungin in the treatment of invasive aspergillosis
    Mabel Aoun · 2006 · Medical Mycology
  21. Outcome of Candida parapsilosis complex infections treated with caspofungin in children
    İlker Devrim, Rana İşgüder, Hasan Ağın, Nuri Bayram, Gökhan Ceylan, Fahri Yüce Ayhan, Özlem Saraç Sandal, Ferhat Sarı, Ahu Kara Aksay, Mine Uzunsoy Duzgol · 2016 · Mediterranean Journal of Hematology and Infectious Diseases
  22. Influence of Fungicidal Activity againstCandida tropicalison the Efficacy of Micafungin and Liposomal Amphotericin B in a Neutropenic Murine Lethal Infection Model
    Koji Takemoto, Tatsuo Nakayama, Katsunori Kanazawa, Yutaka Ueda · 2012 · Pharmacology
  23. Sex Pili Mutants Isolated by Macarbomycin Treatment
    Shizuko Iyobe, S Mitsuhashi, Tetsu Saito · 1973 · Antimicrobial Agents and Chemotherapy
  24. Experimental efficacy of anidulafungin againstAspergillus terreusspecies complex
    Marta Sanchis, Javier Capilla, Emilio Mayayo, Francisco Javier Pastor, Josep Guarro · 2015 · Medical Mycology
  25. Safety of micafungin in prospective and retrospective clinical trials
    Andrew J. Ullmann, Wibke Klaas · 2012 · Mycoses
  26. Antifungal Therapy in the Intensive Care Unit
    José Artur Paiva, José Manuel Pereira · 2007 · Springer eBooks
  27. Candida albicans signalling pathways and the regulation of cell wall biosynthesis under stress
    De Almeida Nogueira, Maria Carmela Filomena · 2013
  28. The activity of micafungin against clinical isolates of non-albicans Candida spp.
    Anna Biernasiuk, Ewelina Dobiecka, Grazyna Zdzienicka, Anna Malm · 2015 · Current Issues in Pharmacy and Medical Sciences
  29. Novel, broad-specrum antimycotic agents: the role of echinocandins today
    Roberto Manfredi · 2010 · Redalyc (Universidad Autónoma del Estado de México)
  30. Comparative Antifungal Activity of Cilofungin (LY121019) against Candida Species, Including Evaluation of Susceptibility Testing Method
    Abdul Hamid Chagla, John H. Hii, Daryl J. Hoban · 1991 · Canadian Journal of Infectious Diseases and Medical Microbiology
  31. Overview of Safety Experience with Caspofungin (CAS) in Clinical Trials
    Nicholas A. Kartsonis · 2005 · 43rd Annual Meeting